C M Brett - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C M Brett

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Clinical Pharmacology and Therapeutics|July 5, 2007

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokineticsY Shu, C Brown, R A Castro, et al.

The Pharmacogenomics Journal|March 2, 2005

Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)I Badagnani, W Chan, R A Castro, et al.

Clinical Pharmacology and Therapeutics|December 27, 2012

The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.

Clinical Pharmacology and Therapeutics|March 7, 2007

The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Clinical Pharmacology and Therapeutics|July 5, 2007

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokineticsY Shu, C Brown, R A Castro, et al.

The Pharmacogenomics Journal|March 2, 2005

Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)I Badagnani, W Chan, R A Castro, et al.

Clinical Pharmacology and Therapeutics|December 27, 2012

The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.

Clinical Pharmacology and Therapeutics|March 7, 2007

The pharmacogenetics research network: from SNP discovery to clinical drug responseK M Giacomini, C M Brett, R B Altman, et al.

Pageof 4